CELLDEX THERAPEUTICS INC NEW's ticker is CLDXXXXX and the CUSIP is 15117B103. A total of 152 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q3 2013. The put-call ratio across all filers is 0.41 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2015 | $9,000 | -57.1% | 600 | -70.0% | 0.01% | -52.9% |
| Q3 2015 | $21,000 | +40.0% | 2,000 | +233.3% | 0.02% | +88.9% |
| Q4 2013 | $15,000 | -40.0% | 600 | -14.3% | 0.01% | -40.0% |
| Q3 2013 | $25,000 | -46.8% | 700 | -76.7% | 0.02% | -54.5% |
| Q2 2013 | $47,000 | – | 3,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TSP Capital Management Group, LLC | 844,981 | $15,421,000 | 7.11% |
| DOHENY ASSET MANAGEMENT /CA | 195,345 | $3,565,000 | 1.70% |
| First Light Asset Management, LLC | 153,617 | $2,804,000 | 1.59% |
| Rhenman & Partners Asset Management AB | 175,000 | $3,194,000 | 0.93% |
| Iguana Healthcare Management, LLC | 100,000 | $1,825,000 | 0.88% |
| Eventide Asset Management | 288,700 | $5,269,000 | 0.58% |
| Bedell Frazier Investment Counselling, LLC | 60,820 | $1,110,000 | 0.54% |
| STONERIDGE INVESTMENT PARTNERS LLC | 214,327 | $3,911,000 | 0.52% |
| Fernwood Investment Management, LLC | 31,350 | $572,000 | 0.49% |
| SUFFOLK CAPITAL MANAGEMENT LLC | 168,560 | $3,076,000 | 0.37% |